• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Eli Lilly

Philadelphia Pennsylvania in autumn overlooking Benjamin Franklin Parkway
Biotech

Lilly picks Philadelphia for newest Gateway Labs site

The new Philadelphia site will occupy 44,000 square feet across two floors of a newly developed building in the Center City area.
Gabrielle Masson Nov 19, 2025 6:45am
gold coins with euro sign

European VC Medicxi closes €500M biotech fund

Nov 14, 2025 3:00am
Robot hands with a pieces of the puzzle

Lilly continues AI push, inking $100M-plus deal with Insilico

Nov 10, 2025 9:00am
Close-up of Benjamin Franklins eyes peering through hundred dollar bills

Lilly bags eye-catching gene therapy in $475M deal

Nov 10, 2025 7:00am
Goal disorientation and lack of vision

Lilly pens $1.2B pact with Sanegene to target metabolic RNA meds

Nov 10, 2025 4:05am
parasailing over clouds in Salzburg Austria

Recursion refreshes leadership with CEO swap—Chutes & Ladders

Nov 7, 2025 8:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings